Nurix Therapeutics Stock Discussion

$Nurix Therapeutics(NRIX.US)$ Nurix Therapeutics Inc - Commenced an Underwritten Public Offering of $125 Mln of Its Common Stock

$Annovis Bio(ANVS.US)$ 22% Ph2/3 data reporting update
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...

$Nurix Therapeutics(NRIX.US)$ Nurix Therapeutics (NASDAQ:NRIX) said that the FDA has placed a partial clinical hold on a Phase 1 study of its drug NX-2127 in the treatment of B-cell malignancies as the company’s shifts to a different manufacturing process for the product.
Nurix said patients currently enrolled in the trial who are deriving clinical benefit are allowed to continue receiving the current drug product. The screening and enrollment of new patients has been paused.
The company sai...

$Nurix Therapeutics(NRIX.US)$ Looking interesting here. just off ATL, recent good news. PT just set to 31! will be looking for place to take position for a swing. just thinking outloud

$Nurix Therapeutics(NRIX.US)$ Nurix Therapeutics Announces Collaboration With Seagen To Develop A Portfolio Of Degrader-Antibody Conjugates; Co. To Receive $60M Upfront Payment And Potential For $3.4B In Milestones Plus Royalties

Modest daily stock gains cinched a strong six months on Wall Street, fueled by investors' optimism that inflation is easing while the economy continues to hum. Fresh spending data added momentum on Friday, showing milder core-price increases in May compared with a month earlier, while consumer outlays continued to rise. The data lifted major stock indexes on a day of calm trading, rounding out the $Nasdaq Composite Index(.IXIC.US)$ 's best f...